Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial

Vaccine ◽  
2010 ◽  
Vol 28 (3) ◽  
pp. 840-848 ◽  
Author(s):  
Wendy Keitel ◽  
Nicola Groth ◽  
Maria Lattanzi ◽  
Michaela Praus ◽  
Anne Katrin Hilbert ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Cell Culture ◽  
Influenza Vaccine ◽  
Phase 1 ◽  
Vaccine Safety ◽  
H5n1 Influenza ◽  
A Cell ◽  
Dose Ranging

Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial

Vaccine ◽  
2015 ◽  
Vol 33 (41) ◽  
pp. 5437-5444 ◽  
Author(s):  
Joon Young Song ◽  
Hee Jin Cheong ◽  
Jacob Lee ◽  
Heung Jeong Woo ◽  
Seong-Heon Wie ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Cell Culture ◽  
Influenza Vaccine ◽  
Phase 3 ◽  
Double Blind ◽  
Trivalent Influenza Vaccine ◽  
A Cell

scholarly journals DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial

PLoS ONE ◽  
2018 ◽  
Vol 13 (11) ◽  
pp. e0206837 ◽  
Author(s):  
Katherine V. Houser ◽  
Galina V. Yamshchikov ◽  
Abbie R. Bellamy ◽  
Jeanine May ◽  
Mary E. Enama ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Influenza Vaccine ◽  
Children And Adolescents ◽  
Randomized Clinical Trial ◽  
Dna Vaccine ◽  
Seasonal Influenza ◽  
Phase 1 ◽  
Seasonal Influenza Vaccine

Efficacy of a Cell-Culture–Derived Quadrivalent Influenza Vaccine in Children

2021 ◽  
Vol 385 (16) ◽  
pp. 1485-1495
Author(s):  
Terence Nolan ◽  
Alexandre C. Fortanier ◽  
Brett Leav ◽  
Airi Põder ◽  
Lulu C. Bravo ◽  
...  
Keyword(s):  
Cell Culture ◽  
Influenza Vaccine ◽  
A Cell ◽  
Quadrivalent Influenza Vaccine

scholarly journals Clinical phase II and III studies of an AS03‐adjuvanted H5N1 influenza vaccine produced in an EB66 ® cell culture platform

2020 ◽  
Vol 14 (5) ◽  
pp. 551-563
Author(s):  
Masafumi Endo ◽  
Mitsuyoshi Tanishima ◽  
Kayo Ibaragi ◽  
Kenshi Hayashida ◽  
Tadashi Fukuda ◽  
...  
Keyword(s):  
Cell Culture ◽  
Influenza Vaccine ◽  
Phase Ii ◽  
Clinical Phase ◽  
H5n1 Influenza ◽  
Phase Ii And Iii
Sign in / Sign up

Export Citation Format

Share Document